Nerve News and Research

RSS

Potential therapeutic target for multiple sclerosis

Oregon Health & Science University neuroscientists are eyeing a protein as a potential therapeutic target for multiple sclerosis because de-activating it protects nerve fibers from damage.

24 Apr 2007

New direction for therapies to treat amyotrophic lateral sclerosis

Researchers from The Ludwig Institute and the University of California, San Diego (UCSD) School of Medicine have discovered that when motor neurons damaged by amyotrophic lateral sclerosis (ALS), or Lou Gehrig?s disease, inappropriately send the wrong signal, immune cells react by killing the messenger.

24 Apr 2007

Non-coplanar PCBs and related chemicals warrant serious attention for health reasons

Scientists have determined that a specific class of PCB causes significant developmental abnormalities in rat pups whose mothers were exposed to the toxicant in their food during pregnancy and during the early weeks when the pups were nursing.

24 Apr 2007

Origin of the brain lies in a worm

The rise of the central nervous system (CNS) in animal evolution has puzzled scientists for centuries.

21 Apr 2007

Talk beyond pain: Understanding diabetic nerve pain

Results from a new survey of more than 600 physicians who treat diabetic peripheral neuropathic pain, or diabetic nerve pain, reveal that nearly all (97 percent) believe that the condition is often misdiagnosed.

20 Apr 2007

Online gambling adds new risks for gamblers with Parkinson's disease

Parkinson's disease sufferers could be adversely affected by the growth of betting on the web because they are more likely to become gambling addicts, says a doctor writing in the British Medical Journal.

20 Apr 2007

Local corticosteroid injection for carpal tunnel syndrom

A single corticosteroid injection in the wrist can offer at least a month of relief to people suffering from severe carpal tunnel syndrome, according to an updated review of studies by Canadian researchers.

20 Apr 2007

New understanding of genetics behind Noonan Syndrome

Researchers have discovered that the genetic malfunction that causes a form of mental retardation called Noonan Syndrome (NS) produces an imbalance in the genesis of two types of cells in the developing embryonic brain.

19 Apr 2007

Researchers observer proteins important in Alzheimer's, Parkinson's moving along axons

Using a novel video-imaging system, researchers at the University of Pennsylvania School of Medicine have been able to observe proteins important in Alzheimer's and Parkinson's disease moving along axons, extensions of nerve cells that carry proteins away from the cell body.

18 Apr 2007

Collagen injected meatballs!

Injecting meatballs with collagen can help the meat to retain the important nutrients iodine and thiamine, a new study by researchers from the Agricultural University of Poznan in Poland shows.

18 Apr 2007

New combined imaging promises insights into multiple sclerosis

Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.

18 Apr 2007

New hope for spinal cord injury sufferers

Spinal cord injury (SCI) is one of the most significant forms of neurotrauma with major economic and social impact.

17 Apr 2007

Single master gene crucial for nerve cell insulation

Researchers funded by the National Institutes of Health have discovered how a defect in a single master gene disrupts the process by which several genes interact to create myelin, a fatty coating that covers nerve cells and increases the speed and reliability of their electrical signals.

17 Apr 2007

Study identifies trends in cerebral aneurysm treatment

Cerebrovascular disease is a leading cause of serious long-term disability, affecting as many as 700,000 people every year.

17 Apr 2007

Effective noninvasive treatment option for trigeminal neuralgia-related pain

Trigeminal neuralgia or tic douloureux is sometimes described as the most excruciating pain known to humanity.

17 Apr 2007

Natalizumab (Tysabri) reduces vision loss in MS patients

According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI), a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS), also reduces vision loss in patients with relapsing MS.

17 Apr 2007